Synapse - Marc Ladanyi

Results (1336)

Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms

Journal Article

Durham, B. H.; Lopez Rodrigo, E.; Picarsic, J.; Abramson, D.; Rotemberg, V.; De Munck, S.; Pannecoucke, E.; Lu, S. X.; Pastore, A.; Yoshimi, A.; more...
Nature Medicine (2019)

Fulltext@MSK | Save

Analysis of tumor genomic pathway alterations using broad-panel next-generation sequencing in surgically resected lung adenocarcinoma

Journal Article

Zhou, J.; Sanchez-Vega, F.; Caso, R.; Tan, K. S.; Brandt, W. S.; Jones, G. D.; Yan, S.; Adusumilli, P. S.; Bott, M.; Huang, J.; more...
Clinical Cancer Research (2019)

Fulltext@MSK | Save

Comprehensive next-generation sequencing unambiguously distinguishes separate primary lung carcinomas from intrapulmonary metastases: Comparison with standard histopathologic approach

Journal Article

Chang, J. C.; Alex, D.; Bott, M.; Tan, K. S.; Seshan, V.; Golden, A.; Sauter, J. L.; Buonocore, D. J.; Vanderbilt, C. M.; Gupta, S.; more...
Clinical Cancer Research (2019)

Fulltext@MSK | Save

Foreword

Editorial

Hyman, D. M.; Ladanyi, M.
Annals of Oncology (2019)

Fulltext@MSK | Save

Elucidating mechanisms of resistance to targeted therapies in mutant EGFR or KRAS driven lung adenocarcinoma harboring dual loss of p53 and RB1

Meeting Abstract

Inoue, Y.; Somwar, R.; Ladanyi, M.; Lockwood, W.
Journal of Thoracic Oncology (2019)

Fulltext@MSK | Save

A novel activating MAP2K1 in-frame deletion mediates acquired resistance to ROS1 TKIs in a patient with ROS1 fusion-positive NSCLC

Meeting Abstract

Sato, H.; Schoenfeld, A.; Siau, E.; Suzawa, K.; Yue, C.; Offin, M.; Drilon, A.; Davare, M.; Riely, G.; Ladanyi, M.; more...
Journal of Thoracic Oncology (2019)

Fulltext@MSK | Save

A phase 2 trial of cabozantinib in ROS1-rearranged lung adenocarcinoma

Meeting Abstract

Guo, R.; Preeshagul, I.; Schoenfeld, A.; McCarthy, C.; Makhnin, A.; Plodkowski, A.; Ginsberg, M.; Davare, M.; Delasos, L.; Somwar, R.; more...
Journal of Thoracic Oncology (2019)

Fulltext@MSK | Save

Tissue-based molecular and histologic landscape of acquired resistance to osimertinib in patients with EGFR-mutant lung cancers

Meeting Abstract

Schoenfeld, A.; Chan, J.; Rizvi, H.; Somwar, R.; Kubota, D.; Daneshbod, Y.; Chang, J.; Offin, M.; Arcila, M.; Pe'Er, D.; more...
Journal of Thoracic Oncology (2019)

Fulltext@MSK | Save

A clinical utility study of plasma DNA next generation sequencing guided treatment of uncommon drivers in advanced non-small-cell lung cancers

Meeting Abstract

Tu, H.; Xu, C.; Tong-Li, C.; Offin, M.; Razavi, P.; Schapira, E.; Namakydoust, A.; Lee, A.; Pavlakis, N.; Clarke, S.; more...
Journal of Thoracic Oncology (2019)

Fulltext@MSK | Save

Novel germline mutations in DNA-damage repair and DNA replication identified in patients with malignant pleural mesothelioma (MPM)

Meeting Abstract

Guo, R.; Duboff, M.; Kris, M.; Ladanyi, M.; Mandelker, D.; Zauderer, M.
Journal of Thoracic Oncology (2019)

Fulltext@MSK | Save